| WKN: | A1KAGC |
| ISIN: | DK0060448595 |
| Land: | Dänemark |
| Branche: | Chemie, Pharma, Bio- & Medizintechnik |
| Sektor: | Medizintechnik |
Weshalb die Coloplast-Aktie
ein B-Rating hat,
erfahren Sie im Performance-Check
vom 05. Dezember 2025 Info.
| Rang | Datum | Vorjahr | Schluss | Performance |
|---|---|---|---|---|
| 1 | 2012 | 21,96 | 37,40 | 70,29% |
| 2 | 2010 | 12,68 | 20,41 | 60,98% |
| 3 | 2014 | 48,01 | 69,50 | 44,77% |
| 4 | 2019 | 80,88 | 111,15 | 37,43% |
| 5 | 2009 | 9,79 | 12,68 | 29,51% |
| 6 | 2013 | 37,40 | 48,01 | 28,36% |
| 7 | 2021 | 126,90 | 156,40 | 23,25% |
| 8 | 2018 | 66,61 | 80,88 | 21,42% |
| 9 | 2020 | 111,15 | 126,90 | 14,17% |
| 10 | 2011 | 20,41 | 21,96 | 7,63% |
| 11 | 2015 | 69,50 | 74,40 | 7,05% |
| 12 | 2017 | 64,46 | 66,61 | 3,34% |
| 13 | 2024 | 104,10 | 105,95 | 1,78% |
| 14 | 2023 | 110,20 | 104,10 | -5,54% |
| 15 | 2016 | 74,40 | 64,46 | -13,36% |
| 16 | 2008 | 11,77 | 9,79 | -16,87% |
| 17 | 2025 | 105,95 | 77,72 | -26,64% |
| 18 | 2022 | 156,40 | 110,20 | -29,54% |
| Rang | Datum | Vorjahr | Schluss | Performance |
|---|---|---|---|---|
| 1 | 2022 | 156,40 | 110,20 | -29,54% |
| 2 | 2025 | 105,95 | 77,72 | -26,64% |
| 3 | 2008 | 11,77 | 9,79 | -16,87% |
| 4 | 2016 | 74,40 | 64,46 | -13,36% |
| 5 | 2023 | 110,20 | 104,10 | -5,54% |
| 6 | 2024 | 104,10 | 105,95 | 1,78% |
| 7 | 2017 | 64,46 | 66,61 | 3,34% |
| 8 | 2015 | 69,50 | 74,40 | 7,05% |
| 9 | 2011 | 20,41 | 21,96 | 7,63% |
| 10 | 2020 | 111,15 | 126,90 | 14,17% |
| 11 | 2018 | 66,61 | 80,88 | 21,42% |
| 12 | 2021 | 126,90 | 156,40 | 23,25% |
| 13 | 2013 | 37,40 | 48,01 | 28,36% |
| 14 | 2009 | 9,79 | 12,68 | 29,51% |
| 15 | 2019 | 80,88 | 111,15 | 37,43% |
| 16 | 2014 | 48,01 | 69,50 | 44,77% |
| 17 | 2010 | 12,68 | 20,41 | 60,98% |
| 18 | 2012 | 21,96 | 37,40 | 70,29% |